|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Song H, Zhang Y, Liu N, Wan C, Zhang D,
Zhao S, Kong Y and Yuan L: miR-92b regulates glioma cells
proliferation, migration, invasion, and apoptosis via PTEN/Akt
signaling pathway. J Physiol Biochem. 72:201–211. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gu J, Xu R, Li Y, Zhang J and Wang S:
MicroRNA-218 modulates activities of glioma cells by targeting
HMGB1. Am J Transl Res. 8:3780–3790. 2016.PubMed/NCBI
|
|
4
|
Marumoto T and Saya H: Molecular biology
of glioma. Adv Exp Med Biol. 746:2–11. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ambros V: microRNAs: Tiny regulators with
great potential. Cell. 107:823–826. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhou Y, Yang C, Wang K, Liu X and Liu Q:
MicroRNA-33b inhibits the proliferation and migration of
osteosarcoma cells via targeting hypoxia-inducible factor-1α. Oncol
Res. 25:397–405. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang M, Zhai X, Ge T, Yang C and Lou G:
MiR-181a-5p promotes proliferation and invasion, and inhibits
apoptosis of cervical cancer cells via regulating inositol
polyphosphate-5-phosphatase A (INPP5A). Oncol Res. 26:703–712.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang Y, Li J, Xu C and Zhang X:
MicroRNA-139-5p inhibit cell proliferation and invasion by
targeting RHO-associated Coiled-coil containing protein kinase 2 in
ovarian cancer. Oncol Res. Jun 14–2017.(Epub ahead of print).
|
|
10
|
Wang C, Zhou B, Liu M, Liu Y and Gao R:
miR-126-5p restoration promotes cell apoptosis in cervical cancer
by targeting Bcl2l2. Oncol Res. 25:463–470. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhu Y, Zhao H, Rao M and Xu S:
MicroRNA-365 inhibits proliferation, migration and invasion of
glioma by targeting PIK3R3. Oncol Rep. 37:2185–2192. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang T, Ma G, Zhang Y, Huo H and Zhao Y:
miR-599 inhibits proliferation and invasion of glioma by targeting
periostin. Biotechnol Lett. 39:1325–1333. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li S, Zeng A, Hu Q, Yan W, Liu Y and You
Y: miR-423-5p contributes to a malignant phenotype and temozolomide
chemoresistance in glioblastomas. Neuro Oncol. 19:55–65. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yoneyama K, Ishibashi O, Kawase R, Kurose
K and Takeshita T: miR-200a, miR-200b and miR-429 are Onco-miRs
that target the PTEN gene in endometrioid endometrial carcinoma.
Anticancer Res. 35:1401–1410. 2015.PubMed/NCBI
|
|
15
|
Yang X, Wang J, Qu S, Zhang H, Ruan B, Gao
Y, Ma B, Wang X, Wu N, Li X, et al: MicroRNA-200a suppresses
metastatic potential of side population cells in human
hepatocellular carcinoma by decreasing ZEB2. Oncotarget.
6:7918–7829. 2015.PubMed/NCBI
|
|
16
|
Yu SJ, Hu JY, Kuang XY, Luo JM, Hou YF, Di
GH, Wu J, Shen ZZ, Song HY and Shao ZM: MicroRNA-200a promotes
anoikis resistance and metastasis by targeting YAP1 in human breast
cancer. Clin Cancer Res. 19:1389–1399. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Guo T, Zhang Y, Qu X, Che X, Li C, Fan Y,
Wan X, Ma R, Hou K, Zhou H, et al: miR-200a enhances TRAIL-induced
apoptosis in gastric cancer cells by targeting A20. Cell Biol Int.
42:506–514. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zang Y, Tai Y, Wan B and Jia X:
miR-200a-3p promotes the proliferation of human esophageal cancer
cells by post-transcriptionally regulating cytoplasmic collapsin
response mediator protein-1. Int J Mol Med. 38:1558–1564. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Peng F, Jiang J, Yu Y, Tian R, Guo X, Li
X, Shen M, Xu M, Zhu F, Shi C, et al: Direct targeting of
SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma
tumourigenesis and metastasis. Br J Cancer. 109:3092–3104. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Su Y, He Q, Deng L, Wang J, Liu Q, Wang D,
Huang Q and Li G: MiR-200a impairs glioma cell growth, migration,
and invasion by targeting SIM2-s. Neuroreport. 25:12–17.
2014.PubMed/NCBI
|
|
21
|
Qiu M, Bao W, Wang J, Yang T, He X, Liao Y
and Wan X: FOXA1 promotes tumor cell proliferation through AR
involving the Notch pathway in endometrial cancer. BMC Cancer.
14:782014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Robinson JL and Carroll JS: FoxA1 is a key
mediator of hormonal response in breast and prostate cancer. Front
Endocrinol (Lausanne). 3:682012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Guo W, Keener AL, Jing Y, Cai L, Ai J,
Zhang J, Fisher AL, Fu G and Wang Z: FOXA1 modulates EAF2
regulation of AR transcriptional activity, cell proliferation, and
migration in prostate cancer cells. Prostate. 75:976–987. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Horimoto Y, Arakawa A, Harada-Shoji N,
Sonoue H, Yoshida Y, Himuro T, Igari F, Tokuda E, Mamat O, Tanabe
M, et al: Low FOXA1 expression predicts good response to
neo-adjuvant chemotherapy resulting in good outcomes for luminal
HER2-negative breast cancer cases. Br J Cancer. 112:345–351. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu J, Chen B, Yue B and Yang J:
MicroRNA-212 suppresses the proliferation and migration of
osteosarcoma cells by targeting forkhead box protein A1. Exp Ther
Med. 12:4135–4141. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ma CC, Xiong Z, Zhu GN, Wang C, Zong G,
Wang HL, Bian EB and Zhao B: Long non-coding RNA ATB promotes
glioma malignancy by negatively regulating miR-200a. J Exp Clin
Cancer Res. 35:902016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Berthois Y, Delfino C, Metellus P, Fina F,
Nanni-Metellus I, Al Aswy H, Pirisi V, Ouafik L and Boudouresque F:
Differential expression of miR200a-3p and miR21 in grade II-III and
grade IV gliomas: Evidence that miR200a-3p is regulated by
O6-methylguanine methyltransferase and promotes
temozolomide responsiveness. Cancer Biol Ther. 15:938–950. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zheng L, Qian B, Tian D, Tang T, Wan S,
Wang L, Zhu L and Geng X: FOXA1 positively regulates gene
expression by changing gene methylation status in human breast
cancer MCF-7 cells. Int J Clin Exp Pathol. 8:96–106.
2015.PubMed/NCBI
|
|
30
|
Wang L, Qin H, Li L, Feng F, Ji P, Zhang
J, Li G, Zhao Z and Gao G: Forkhead-box A1 transcription factor is
a novel adverse prognosis marker in human glioma. J Clin Neurosci.
20:654–658. 2013. View Article : Google Scholar : PubMed/NCBI
|
